Voranigo 40 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FY9JV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,095
Award facts
- Contract value 100% obligated
- $27,094.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $27,094.95 by the Defense Logistics Agency on August 14, 2025, for the supply of Voranigo 40 mg tablets (30-count units). This non-set-aside competitive award is scheduled for completion by September 5, 2025, with performance taking place at the company's Conshohocken facility. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
As a critical vendor in the federal medical procurement ecosystem, AmerisourceBergen Drug Corp demonstrates significant capacity to fulfill pharmaceutical needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contract portfolio reflects consistent competitively awarded delivery orders with firm fixed pricing, spanning specialty medications, brand-name and generic drugs, vaccines, and specialized medical supplies across multiple therapeutic domains. This particular award represents a routine transactional delivery under the established IDC framework, supporting the Defense Logistics Agency's medical supply chain operations.
Quick answers
Who was awarded contract SPE2DB25FY9JV?
SPE2DB25FY9JV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 14, 2025.
How much is contract SPE2DB25FY9JV worth?
The government has obligated $27,095 on SPE2DB25FY9JV.
Is contract SPE2DB25FY9JV an order under another contract?
Yes. SPE2DB25FY9JV is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB25FY9JV competed?
The extent of competition for SPE2DB25FY9JV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award